Rheumatic fever and post-streptococcal arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 16, Issue 3, 2002, Pages 481-494

  Hilário, Maria Odete E ^a   Terreri, Maria Teresa S L R A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti streptolysin; Carditis; Echocardiography; Penicillin; Post streptococcal arthritis; Rheumatic fever; Streptococcus

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTISTREPTOLYSIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CELL ADHESION MOLECULE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CORTICOSTEROID; CYTOKINE; DIGITALIS GLYCOSIDE; DIURETIC AGENT; ERYTHROMYCIN; GLUCOCORTICOID; HALOPERIDOL; IMMUNOGLOBULIN; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PIMOZIDE; PREDNISONE; SALICYLIC ACID DERIVATIVE; STREPTOCOCCUS VACCINE; SULFADIAZINE; VALPROIC ACID; SALICYLIC ACID; PENICILLIN DERIVATIVE;

BACTERIAL ARTHRITIS; CARDITIS; CENTRAL NERVOUS SYSTEM DISEASE; CHOREA MINOR; DOPPLER ECHOCARDIOGRAPHY; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; HEART FAILURE; HUMAN; IMMUNOGENICITY; MOLECULAR MIMICRY; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; SECONDARY PREVENTION; SKIN MANIFESTATION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; T LYMPHOCYTE; THORAX RADIOGRAPHY; TONSILLECTOMY; ALLERGY; BETA HEMOLYTIC STREPTOCOCCUS; CHOREA; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; INFECTIOUS ARTHRITIS; LABORATORY DIAGNOSIS; REACTIVE ARTHRITIS; RHEUMATIC HEART DISEASE; SKIN DISEASE; CHILD; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CHILD; HUMANS; PENICILLIN G, BENZATHINE; PENICILLINS; RHEUMATIC HEART DISEASE; STREPTOCOCCAL INFECTIONS;

EID: 0038341697     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(02)90255-X     Document Type: Review

References (88)

1. Jones TD. The diagnosis of rheumatic fever. JAMA 1944; 126: 481-484.
2. Stollerman GH. Rheumatic fever. Lancet 1977; 349: 935-942.
3. Gibfsky A, Kerwar S & Zabriskie JB. Rheumatic fever. The relationship between host, microbe and genetics. Rheumatic Disease Clinics of North America 1998; 24: 237-259.
4. Gonçalves HAT. O programa de prevenção da FR no Brasil ('Prevention program of rheumatic fever in Brazil'). In Sheila KO & Azevedo ED (eds) Reumatologia Pediatrica, 2nd edn, pp 392-399. Rio de Janeiro: Revinter, 2001.
5. WHO Cardiovascular Diseases Unit and principal investigators. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: Report from phase I (1986-90). Bulletin of the World Health Organization 1992; 70: 213-218.
6. Flight RJ. The Northland Rheumatic fever register. New Zealand Medical Journal 1991; 97: 263-271.
7. Grover A, Dhawan A, Iyengar SD et al. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bulletin of the World Health Organization 1993; 710: 59-66.
8. Ronchezel MV, Hilário MO, Forléo LHA et al. The use of haloperidol and valproate in children with Sydenham chorea. Indian Pediatrics 1998; 35: 1215-1217.
9. Brownell KD & Bailen-Rose F. Acute rheumatic fever in children: Incidence in a borough of New York city. JAMA 1973; 224: 1593-1597.
10. Amigo MC, Martinez-Lavin M & Reyes PA. Acute rheumatic fever. Rheumatic Disease Clinics of North America 1993; 19: 333-350.
11. Terreri MT, Ferraz MB, Goldenberg J et al. Resource utilization and cost of rheumatic fever. Journal of Rheumatology 2001; 28: 1394-1397.
12. Hafez M, El Shennaway E, El-Ziny M & Khashaba M. Presumptive evidence for an immunosuppressor susceptibility gene, linked to HLA in rheumatic fever. Disease Markers 1987; 5: 177-185.
13. Patarroyo ME, Winchester RJ & Vejerano A. Association of a B cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278: 173-177.
14. Khana AK, Buskirk DR & Williams RC Jr. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. Journal of Clinical Investigation 1989; 83: 1710-1716.
15. Swedo SE, Leonard HL, Mittleman BB et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. American Journal of Psychiatry 1997; 154: 110-112.
16. Anastasiou-Nana MI, Anderson JL, Carlquist JF & Nanuas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: A search for immune response factors. American Heart Journal 1986; 112: 992-997.
17. Carlquist JF, Ward RH, Meyer KJ et al. Immune response factors in rheumatic heart disease: Meta-analysis of HLA-DR associations and evaluation of additional class II alleles. Journal of the American College of Cardiology 1995; 26: 452-457.
18. Jinghan B, Mehra NK, Reddy KS et al. HLA blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 1986; 27: 172-178.
19. Visentainer JEL, Pereira FC, Dalalio MMO et al. Association of HLA-DR7 with rheumatic fever in the Brazilian population. Journal of Rheumatology 2000; 17: 1518-1520.
20. Guilherme L, Weidebach W, Kiss MH et al. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995-1998.
21. Gerbase-DeLima M, Scala LCN, Temin J et al. Rheumatic fever and the HLA complex. A cosegregation study. Circulation 1994; 89: 138-141.
22. Bhatnagar A, Grover A & Ganguly NK. Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients. Clinical and Experimental Immunology 1999; 116: 100-106.
23. Calveti PA. Autoantibodies in rheumatic fever. Proceedings of the Society of Experimental Biology and Medicine 1945; 60: 379-381.
24. Veasy LG & Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatric Infectious Diseases Journal 1997; 16: 400-407.
25. Khanna AK, Nomura Y, Fischetti VA & Zabriskie JB. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin. Journal of Autoimmunity 1997; 10: 99-106.
26. Ayoub EM & Kaplan E. Host-parasite interaction in the pathogenesis of rheumatic fever. Journal of Rheumatology 1991; 18 (supplement 30): 6-10.
27. Hirata AA & Terasaki PI. Cross-reactions between streptococcal M proteins and human transplantation antigens. Science 1970; 168: 1095-1096.
28. Goldenstein-Schainberg C, Vendramini MBG, Kiss MH et al. Antibodies to a ribosomal 24-33 kDa doublet of human central nervous system in rheumatic (Sydenham's) chorea. Arthritis & Rheumatism 1996; 39: S305.
29. Svartman M, Potter EV & Poon-King T. Immunoglobulin components in synovial fluids of patients with acute rheumatic fever. Journal of Clinical Investigation 1975; 56: 111-117.
30. Kawakami K & Hokonohara M. Circulating immune complexes in rheumatic fever. Japanese Circulation Journal 1982; 46: 1188-1192.
31. Etzioni AB, Levy T, Greif Z et al. Transient immunoregulatory perturbation during the acute phase of rheumatic fever. Journal of Clinical and Laboratory Immunology 1986; 20: 7-9.
32. Kutukçuler N & Narin N. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Scandinavian Journal of Rheumatology 1995; 24: 383-385.
33. Yegin O, Coskun M & Ertug H. Cytokines in acute rheumatic fever. European Journal of Pediatrics 1997; 156: 25-29.
34. Roberts S, Koasanke S, Dunn ST et al. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. Journal of Infectious Diseases 2001; 183: 507-511.
35. Guilherme L, Oshiro SE, Faé KC et al. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infection & Immunity 2001; 69: 5345-5351.
36. Badr-Eldin MK. Solving the problem of the pathogenesis of rheumatic fever. Annals of Tropical Paediatrics 1996; 16: 113-121.
37. Murphy G. The characteristic rheumatic lesions of striated and non-striated or smooth muscle cells of the heart. Medicine (Baltimore) 1963; 42: 73-118.
38. Fraser W, Haffejee Z, Jankelow D et al. Rheumatic Aschoff nodules revisited. II Cytokine expression corroborates recently proposed sequential stages. Histopathology 1997; 31: 460-464.
39. Kemeny E, Grieve T, Marcus R et al. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clinical Immunology and Immunopathology 1989; 52: 225-237.
40. Silva CH. Rheumatic fever: A multicenter study in the state of São Paulo. Pediatric Committee - São Paulo Pediatric Rheumatology Society. Revista Hospital Faculdade Medicina São Paulo 1999; 54: 85-90.
41. Dajani AS, Ayoub E & Bierman FZ. Special writing group of the committee on rheumatic fever, endocarditis and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever - Jones Criteria, 1992 update. JAMA 1992; 268: 2069-2073.
42. Hilário MOE, Andrade JL, Gasparian AB et al. The value of echocardiography in the diagnosis and follow-up of rheumatic carditis in children and adolescents: A two-year prospective study. Journal of Rheumatology 2000; 27: 1082-1086.
43. Wilson NJ & Neutze JM. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. International Journal of Cardiology 1995; 50: 1-6.
44. Taranta A. Rheumatic fever: Clinical aspects. In Hollander JL (ed.) Arthritis and Allied Conditions, 7th edn. Philadelphia: Lea & Febiger, 1966.
45. Hilário MOE, Len C, Goldenberg J et al. Febre reumática: Manifestacoes articulares atipicas. ('Rheumatic fever: Atypical articular involvement'). Revista Associacao Medica Brasileira 1992; 38: 214-216.
46. Hicks R & Yim G. Post-streptococcal reactive arthritis - A manifestation of acute rheumatic fever. Arthritis & Rheumatism 1990; 33 (supplement): S45.
47. Pileggi GCS & Ferriani VPL. Manifestações articulares-atípicas em criancas com febre reumatica. ('Atypical articular involvement in children with rheumatic fever'). Jornal Pediatria 2000; 76: 49-54.
48. De Cunto CL, Giannini EH, Fink CW et al. Prognosis of children with poststreptococcal reactive arthritis. Pediatric Infectious Diseases Journal 1988; 7: 683-686.
49. Olivera SKF. Artrite reativa pós-estreptocócica ou febre reumatica atipica? ('Post-streptococcal reactive arthritis or atypical rheumatic fever?'). Revista Brasileira Reumatologia 1997; 37: 103-108.
50. Goldenberg J, Ferraz MB, Hilário MO et al. Increase in incidence of Sydenham's chorea in São Paulo, Brazil. Journal of Tropical Pediatrics 1993; 39: 192-193.
51. Veasy LG, Wiledmeier SE, Orsmond GS et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. New England Journal of Medicine 1987; 316: 421-427.
52. Swedo SE. Sydenham's chorea - A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272: 1788-1791.
53. Mercadante MT, Busatto GF, Lombroso PJ et al. The psychiatric symptoms of rheumatic fever. American Journal of Psychiatry 2000; 157: 2036-2038.
54. Feinstein AR & Spagnuolo M. Mimetic features of rheumatic fever recurrences. New England Journal of Medicine 1960; 262: 533-540.
55. Berrios X, Quesney F. Morales A et al. Are all recurrences of 'pure' Sydenham chorea true recurrences of acute rheumatic fever? Journal of Pediatrics 1985; 107: 867-872.
56. Castillo M, Kwock L & Arbelaez A. Sydenham's chorea: MRI and proton spectroscopy. Neuroradiology 1999; 41: 943-945.
57. Ikuta N, Hirata M, Sasabe F et al. High signal basal ganglia images in a patient with Sydenham's chorea. Neuroradiology 1998; 40: 659-661.
58. Roddey OF, Clegg HW, Martin ES et al. Comparison of an optical immunoassay technique with two culture methods for the detection of group A streptococci in a pediatric office. Journal of Pediatrics 1995; 126: 931-933.
59. Swenson JM, Fischer DR, Miller AS et al. Are chest radiographs and electrocardiograms still valuable in evaluating new pediatric patients with heart murmurs or chest pain? Pediatrics 1997; 99: 1-3.
60. Williamson L, Bowness P, Mowat A & Östman-Smith I. Difficulties in diagnosing acute rheumatic fever - Arthritis may be short lived and carditis silent. British Medical Journal 2000; 320: 362-365.
61. Figueroa FE, Fernandez MS, Valdes P et al. Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: Long term follow up of patients with subclinical disease. Heart 2001; 85: 407-410.
62. Elevli M, Çelebi A, Tombul T & Gökalp AS. Cardiac involvement in Sydenham's chorea: Clinical and doppler echocardiographic findings. Acta Paediatrica 1999; 88: 1074-1077.
63. Trapani S, Grisolia F, Simonini G et al. Incidence of occult cancer in children presenting with musculoskeletal symptoms: A 10-year survey in pediatric rheumatology unit. Seminars in Arthritis & Rheumatism 2000; 29: 348-359.
64. Tarlow MJ. Macrolides in the management of streptococcal pharyngitis/tonsillitis. Pediatric Infectious Diseases Journal 1997; 16: 444-448.
65. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A Streptococci in Finland. New England Journal of Medicine 1997; 337: 441-446.
66. Adam D, Scholz H & Helmerking M. Comparison of short course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. Journal of Antimicrobial Chemotherapy 2000; 45: Suppl: 23-30.
67. Adam D, Scholz H & Helmerking M. Short course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. Journal of Infectious Disease 2000; 182: 509-516.
68. Dajani A, Taubert K, Ferrieri P et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Pediatrics 1995; 96: 758-764.
69. Arquedas A & Mohs E. Prevention of rheumatic fever in Costa Rica. Journal of Pediatrics 1992; 121: 569-572.
70. Voss LM, Wilson NJ, Neutze JM et al. Intravenous immunoglobulin in acute rheumatic fever. A randomized controlled trial. Circulation 2001; 23: 401-405.
71. Dajani A, Bisno A, Chung K et al. Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. The American Heart Association. Circulation 1988; 78: 1082-1086.
72. Taranta A & Markowitz M. Rheumatic recurrences. In Taranta M & Markowitz M (eds) Rheumatic Fever, 2nd edn, p 71. Dordrecht/Boston/London: Kluwer Academic Publishers, 1989.
73. Stollerman GH, Rusoff JH & Hirschfield I. Prophylaxis against group A streptococci in rheumatic fever. New England Journal of Medicine 1955; 252: 787-792.
74. Sarti W. Routine use of skin testing for immediate penicillin allergy to 6764 patients in an outpatient clinic. Annals of Allergy 1985; 55: 157-161.
75. De Shazo RD & Kemp SF. Allergic reactions to drugs and biologic agents. JAMA 1997; 278: 1895-1906.
76. Dale JB. Group A streptococcal vaccines. Pediatric Annals 1998; 27: 301-308.
77. Beachey EH, Bronze M, Dale JB et al. Protective and autoimmune epitopes of streptococcal M proteins. Vaccine 1988; 6: 192-196.
78. Robinson JH & Kehoe MA. Group A streptococcal M proteins: Virulence factors and protective antigens. Immunology Today 1992; 13: 362-367.
79. Dale JB. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 1999; 17: 193-200.
80. Crea MA & Mortimer EA. The nature of scarlatinal arthritis. Pediatrics 1959; 23: 879-884.
81. Goldsmith DP & Long SS. Streptococcal disease of childhood - A changing syndrome. Arthritis & Rheumatism 1982; 25 (Supplement 4): S18.
82. Gibbas DL & Broussard DA. Post-streptococcal reactive polyarthritis - Rheumatic fever or not? Arthritis & Rheumatism 1986; 29 (supplement 4): S92.
83. Ahmed S, Ayoub EM, Scornik JC et al. Poststreptococcal reactive arthritis. Arthritis & Rheumatism 1998; 41: 1096-1102.
84. Bont L, Brus F, Dijkman-Neerincx et al. The clinical spectrum of post-streptococcal syndromes with arthritis in children. Clinical and Experimental Rheumatology 1998; 16: 750-752.
85. Deighton C. Beta haemolytic streptococci and reactive arthritis in adults. Annals of the Rheumatic Diseases 1993; 52: 475-482.
86. Falcini F, Simonini G, Calabri GB & Cimaz R. HLA-DRBI alleles in post-streptococcal reactive arthritis and rheumatic fever do not differ in Italian patients. Arthritis & Rheumatism 2000; 43: S256.
87. Denny FW. T Duckett Jones and rheumatic fever in 1986. Circulation 1987; 76: 963-970.
88. Birdi N, Hosking M, Clulow MK et al. Acute rheumatic fever and poststreptococcal reactive arthritis: Diagnostic and treatment practices of pediatric subspecialists in Canada. Journal of Rheumatology 2001; 28: 1681-1688.